ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
58,587.59
0.60%
S&P 500
5,018.39
0.00%
Dow Jones
37,903.29
0.00%
US Dollar vs Yen
154.4365
-0.82%
Brent Oil
83.575
0.04%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Forte Biosciences Inc (FBRX)

  7. Forte Biosciences Inc (FBRX) ニュース

FBRX Forte Biosciences Inc

0.671
0.00 (0.00%)
プレマーケット
最終更新日： 20:00:00
15分遅延
名称 銘柄コード 市場 種別
Forte Biosciences Inc FBRX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.00 0.00% 0.671 20:00:00
始値 安値 高値 終値 前日終値
0.671
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/2/1706:16EDGAR2Form 8-K/A - Current report: [Amend]
2024/2/1506:54EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/1/0607:27EDGAR2Form SC 13D/A - General statement of acquisition of..
2024/1/0406:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0406:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2100:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1608:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1309:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0909:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0906:05EDGAR2Form 8-K - Current report
2023/11/2307:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1406:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/0405:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0405:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2705:16EDGAR2Form 8-K/A - Current report: [Amend]
2023/9/2106:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2106:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2106:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2106:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2106:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2105:15EDGAR2Form 8-K - Current report
2023/9/2105:05EDGAR2Form 8-K - Current report
2023/9/1505:00EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
2023/9/1423:50BWISS and Glass Lewis Recommend Forte Biosciences Stockholders..
2023/9/1113:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/9/0905:36EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/9/0705:31EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
2023/9/0704:15BWConcerned Stockholders of Forte Biosciences and Its..
2023/9/0206:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/9/0106:29EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
2023/9/0103:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/8/3006:57EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/8/2606:17EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
2023/8/2523:10EDGAR2Form DEFC14A - Definitive proxy statement, contested..
2023/8/2521:00BWConcerned Stockholders of Forte Biosciences File Definitive..
2023/8/2419:15EDGAR2Form DEFC14A - Definitive proxy statement, contested..
2023/8/2405:47EDGAR2Form SC 13D - General statement of acquisition of beneficial..
2023/8/1722:30EDGAR2Form PRRN14A - Non-management revised preliminary proxy..
2023/8/1606:15EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/8/1506:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1022:20EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/8/0505:21EDGAR2Form 8-K - Current report
2023/8/0405:31EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/8/0307:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0307:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0306:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0306:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0306:28EDGAR2Form PREC14A - Preliminary proxy statements, contested..
2023/8/0205:06EDGAR2Form 8-K - Current report
2023/7/0705:08EDGAR2Form SC 13D/A - General statement of acquisition of..

最近閲覧した銘柄

NASDAQ
FBRX
Forte Biosciences
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有